You just read:

BioVentrix Announces First Patient Enrolled in the U.S. arm of IDE Study of the Revivent TC™ TransCatheter Ventricular Enhancement Treatment

News provided by

BioVentrix, Inc.

Oct 04, 2017, 06:00 ET